Patents by Inventor Thomas STRUB

Thomas STRUB has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230416830
    Abstract: Here, in multi-scale analyses using single-cell RNA sequencing of six different primary uveal melanomas, inventors uncover a previously unrecognized intratumor heterogeneity at the genetic and transcriptomic level. They identify distinct transcriptional cell states and diversetumor-associated populations in a subset of primary uveal melanomas. They also decipher a gene regulatory network underlying an invasive and poor prognosis state driven in part by the transcription factor HES6, a member of the NOTCH signaling pathway. HES6 heterogenous expression has been validated by RNAscope assays within primary uveal melanomas, which unveils the existence of these cells conveying a dismal prognosis in tumors diagnosed with a favorable outcome using bulk analyses. Depletion of HES6 impairs growth, migration and metastatic dissemination, demonstrating essential roles of HES6 in uveal melanoma progression.
    Type: Application
    Filed: November 15, 2021
    Publication date: December 28, 2023
    Inventors: Robert BALLOTTI, Thomas STRUB, Charlotte PANDIANI, Corine BERTOLOTTO-BALLOTTI
  • Publication number: 20230416838
    Abstract: Here, in multi-scale analyses using single-cell RNA sequencing of six different primary uveal melanomas, inventors uncover a previously unrecognized intratumor heterogeneity at the genetic and transcriptomic level. They identify distinct transcriptional cell states and diverse tumor-associated populations in a subset of primary uveal melanomas.
    Type: Application
    Filed: November 15, 2021
    Publication date: December 28, 2023
    Inventors: Robert BALLOTTI, Thomas STRUB, Charlotte PANDIANI, Corine BERTOLOTTO-BALLOTTI